RecallDepth
Class II Ongoing

Indomethacin 25mg Capsules, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-406-01

This recall is currently active, issued December 6, 2023. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
November 7, 2023
Posted
December 6, 2023
Recall Number
D-0123-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
37,200 bottles
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen

Distribution

Nationwide

Lot / Code Info

Lot# 19231903; Exp 4/2025 Lot# 19231858; Exp 4/2025 Lot# 19231881; Exp 4/2025 Lot# 19233484; Exp 8/2025 Lot# 19233490; Exp 8/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls